Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Reduce impact on families

The research that is reducing the impact on families done by The Kids Research Institute Australia.

News & Events

Perth researchers lead world-first clinical trial in Chile to stop COVID-19 outbreaks

Perth researchers are leading an international clinical trial focused on preventing the spread of COVID-19 by testing the effectiveness of the drug interferon in reducing the infectiousness of people who contract the virus.

News & Events

Return to school measures build confidence

WA parents and carers can have confidence in sending their children back to school on January 31 with the measures outlined in today’s Safe Return to School Plan.

News & Events

Time for WA’s ‘wait awhiles’ to get vaccinated

Researchers leading a study into COVID-19 vaccine hesitancy say a sub-group of people they’ve dubbed the ‘wait awhiles’

News & Events

Clinical trial to examine whether “mixing” COVID-19 vaccine boosters is more effective

Top infectious disease experts in Australia will lead a clinical trial to determine whether combining different Covid-19 vaccines in the nation’s booster immunisation will increase effectiveness.

News & Events

International COVID-19 ‘risk’ tool launched to reduce community transmission

The Kids Research Institute Australia researchers have collaborated with global experts to launch an online tool designed to assess the risk of contracting COVID-19 and provide advice to reduce transmission.

Research

‘COVID Is Coming, and I’m Bloody Scared’: How Adults with Co-Morbidities’ Threat Perceptions of COVID-19 Shape Their Vaccination Decisions

Australian Aboriginal and/or Torres Strait Islander children in rural/remote areas suffer high rates of persistent otitis media (OM) from early infancy. We aimed to determine the proportion of Aboriginal infants living in an urban area who have OM and investigate associated risk factors.

Research

Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers

The bacille Calmette-Guérin (BCG) vaccine has immunomodulatory "off-target" effects that have been hypothesized to protect against coronavirus disease 2019.